Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
ImmuNOA Pte. Ltd. runs a Biotechnology Research operation from Singapore. Ownership is privately held; it publishes at immunoa.com. It holds one address on record, all in Singapore. The record counts 1 person. Tagged immunotherapy, antisense oligonucleotides and AON. One Singapore registration (UEN) is a confirmed match. The record links eight similar brands, most of them in Biotechnology Research.
UEN201820479N
| IMMUNOA PTE. LTD. | UEN 201820479N |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
In ImmuNOA we rationally design and test antisense oligonucleotides to improve immunotherapy efficacy in the treatment of multiple pathologies.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Singapore entity on ACRA. IMMUNOA PTE. LTD. (UEN 201820479N), high confidence.
The record holds 1 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 77 Ayer Rajah Cres, Singapore, 13.
None linked to this brand.
Five tags on the brand's own list, among them Immunotherapy, Antisense oligonucleotides and AON.
1 profile lists ImmuNOA Pte. Ltd. as a peer — 30th percentile in Biotechnology Research. It lists ten peers of its own. PAC Corporation (Thailand) Co., Ltd. lists it back.